Recent Articles from GlobeNewswire

As the global cryptocurrency market closely watches the next major cycle for Bitcoin, figuring out where its price will go next has once again become a huge conversation piece for everyday traders and financial analysts alike. We are seeing some fresh momentum lately. Fortune recently mentioned that Bitcoin was hovering right around $78,178 on May 1, 2026. At the same time, Barron's pointed out that the coin moved near the $77,000 dollar level, which has been a pretty resilient area for it since early February of that year.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company developing allogeneic invariant natural killer T (iNKT) cell therapies for cancer and immune disorders, today announced data being presented at the American Society of Gene and Cell Therapy Annual Meeting (ASGCT 2026) in Boston, Massachusetts. The data demonstrate that agenT-797, MiNK’s off-the-shelf, allogeneic iNKT cell therapy produces fundamentally different, disease-appropriate immune responses in patients with solid tumors and patients with acute respiratory distress syndrome (ARDS), driven by the intrinsic biology of iNKT cells rather than genetic modification.

– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio –

On track for planned IND submission in mid-2026 and Phase 1 initiation in the second half of 2026 for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2

Groenlo, the Netherlands, May 12, 2026, 07:00 CEST.

HOLLISTON, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced financial results for the first quarter ended March 31, 2026.

LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced financial results for the first quarter ended March 31, 2026, and provided an update on recent corporate developments.

Q1 GAAP revenue of $106.2 million increased 333.5% year-over-year, driven by recently closed M&A transactions

- Phase 3 CALIBRATE primary results were presented in an oral presentation at the 2026 ECE, demonstrating the rapid and durable benefit of encaleret across key clinical parameters in ADH1 

Continued site activation in registrational SAFEGUARD trial of SAB-142; enrollment ongoing and on track to be completed by end of 2026 with topline data expected in 2H 2027

A clear message from the market: investors want to stay invested, generate income, and minimize taxes

Secured equity financing with gross proceeds of $175M in April 2026

ATLANTA, May 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026. Management will present at 2:40pm CST and will also host 1x1 investor meetings that same day. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call.

More than half of renters are over 40, signaling a growing market tied to family protection and high-value assets

– First-ever FDA approved PROTAC supports the further development and potential of Arvinas’ pipeline –

FORT WORTH, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly and fiscal earnings results on Wednesday, May 20, 2026, at 11:30 AM Eastern Time.

Initiated enrollment of Phase 1 Study of PRT12396, mutant-selective JAK2V617F inhibitor in patients with polycythemia vera (PV) and myelofibrosis (MF)

NEO-CYT marks the first evaluation of MDNA11 in earlier-stage cancers, as a potentially curative treatment; extends development beyond the heavily pretreated metastatic setting of the ongoing Phase 1/2 ABILITY-1 study 

GREENWICH, Conn., May 12, 2026 (GLOBE NEWSWIRE) -- American Battery Materials, Inc. (“ABM” or the “Company”) (OTC: BLTH), a U.S.-based critical minerals company focused on lithium and magnesium resource development, today provided an operational update regarding ongoing evaluation activities at its Lisbon Valley Project in San Juan County, Utah.

WELLESLEY HILLS, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below.

RIDGELAND, Miss, May 12, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based food industry, and Sara Lee Frozen Bakery, LLC, a leading manufacturer of premium frozen baked goods, today announced Cal-Maine Foods’ acquisition of certain assets of the Van’s Foods business of Sara Lee Frozen Bakery, LLC, a Kohlberg portfolio company.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Silver X Mining Corp. (TSX-V: AGX; OTCQX: AGXPF) (or “Silver X”), a rapidly growing silver producer-developer, has qualified to trade on the OTCQX® Best Market. Silver X Mining Corp. upgraded to OTCQX from the OTCQB® Venture Market.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ATEX Resources Inc. (TSX: ATX; OTCQX: ATXRF), a company focused on exploration and development of the Valeriano copper-gold-silver-molybdenum project in Chile, has qualified to trade on the OTCQX® Best Market. ATEX Resources Inc. upgraded to OTCQX from the OTCQB® Venture Market.

Houston, Texas and Tuebingen, Germany, May 12, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today provided a business update and reported financial results for the quarter ended March 31, 2026.

SOMERSET, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its first quarter 2026 unaudited financial results and key corporate highlights.

NEWTON, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today reported financial results for the first quarter of 2026 and provided a business update.

WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today reported financial results for the first quarter ended March 31, 2026, as well as recent business highlights.

Consumer Groups Urge DOJ and FTC to Investigate

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today reported its financial and operating results for the quarter ended March 31, 2026, and provided a business update.

– Arvinas and Pfizer to receive $85 million in upfront and transition payments with potential for additional $320 million in development, regulatory, and commercial milestones and tiered royalites on net sales –

Expands aviation, mission critical, and federal expertise across the U.S.

Net Contribution of $258 million, up 19% YoY 

New year-round American IPA balances hop-forward flavor with easy drinkability—available on draft and in 6-pack 12oz cans across NY, CT, PA & NJ

SINGAPORE, May 12, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI and Bitcoin mining infrastructure, today announced its unaudited operations updates for April 2026.

SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced financial results for the first quarter ended March 31, 2026.

CHICAGO, May 12, 2026 (GLOBE NEWSWIRE) -- Amplify ETFs, a leading provider of breakthrough ETF solutions, announces the filing of the Amplify Fairlead Tactical Bitcoin ETF.

Herzliya, Israel, May 12, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced that it will demonstrate its ML-safe video data stack for autonomous vehicles (AV) at Smart Mobility Summit 2026, held from May 17–18 at Expo Tel Aviv. To meet with Beamr’s video experts (booth VT24), use this link

SAN FRANCISCO, May 12, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today reported financial and operating results for the first quarter ended March 31, 2026.

ALMATY, Kazakhstan, May 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of JSC Kaspi.kz (Nasdaq: KSPI) hereby announces the Extraordinary General Meeting of Shareholders of JSC Kaspi.kz will be held on 11 June 2026 at 10:00 Astana time at: 154 “А”, Nauryzbai Batyr Street, Almaty, Kazakhstan, 050013.

Provides EU cultivators and home growers access to the company’s premium genetics through established seed bank platform

LOS ANGELES, May 12, 2026 (GLOBE NEWSWIRE) -- LiveOne, Inc. (Nasdaq: LVO) today announced that its subsidiary, PodcastOne, Inc. (Nasdaq: PODC), has received approximately $5.5 million in cash proceeds from the exercise of warrants of PodcastOne common stock at $3 per share.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today provided business updates including financial results for the first quarter ended March 31, 2026.

LOUISVILLE, Ky., May 12, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, announced today that it will release its financial results for the three months ended March 31, 2026 before the market opens on Friday, May 15, 2026. A conference call to review the results is scheduled for Friday, May 15, 2026, at 9:00 am Eastern Time, which will include prepared remarks and materials from management followed by a live Q&A. The call will be hosted by Rick Mills, Chief Executive Officer, George Sautter, Chief Strategy Officer, and Tamra Koshewa, Chief Financial Officer.

TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX) (OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that it will host a webcast to discuss its first quarter 2026 financial results and provide an update on the Company’s business and market development on Tuesday, May 19th at 10:00 a.m. EDT. The Company expects to release its financial results after market close on May 15, 2026.

Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis; topline data on track for the summer of 2026

WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the H.C. Wainwright 4th Annual Bioconnect Investor Conference, the 2026 Stifel Virtual Targeted Oncology Forum, and the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.

  

LOS ANGELES, May 12, 2026 (GLOBE NEWSWIRE) -- WEBTOON Entertainment Inc. (Nasdaq: WBTN) (“WEBTOON Entertainment” or “the Company”), a leading global entertainment company and home to some of the world’s largest storytelling platforms, today announced it will participate in the following upcoming investor conferences:

Mineralization Extends Beyond Known Resource Near Existing Underground Infrastructure

Current EQT Bid Represents Superior Risk-Adjusted Value to Shareholders

Cambridge, Massachusetts, May 12, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, today announced its financial results for the quarter ended March 31, 2026, and provided a corporate update.

CHANTILLY, Va., May 12, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was selected by the United States Air Force (USAF) and its 75th Civil Engineer Group at Hill Air Force Base for a multiple award task order contract (MATOC) to provide architect-engineer services across the installation. The $136 million ceiling value contract consists of an 8.5-year performance period and represents new work for the company.

CHESTERBROOK, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, today announced its results for its fiscal 2026 first quarter ended April 4, 2026.

HANGZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- On May 7th, the Women's Hospital, School of Medicine of Zhejiang University celebrated its 75th anniversary. Starting as a small maternity and children's hospital by West Lake in Hangzhou, capital city of east China's Zhejiang Province, it has grown into a leading medical institution operating across three modern campuses - Hubin, Qianjiang, and Yuhang - serving patients across Zhejiang, China, and the world.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced the pricing of its offering of $2.6 billion aggregate principal amount of 1.00% convertible senior notes due 2033 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $2 billion aggregate principal amount of notes.

AUSTIN, Texas and NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) today reported financial and operating results for the first quarter 2026. The Company will hold a conference call today at 8:00 am EDT.

BEIJING, May 12, 2026 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the “Company” or “JD.com”), a leading supply chain-based technology and service provider, today announced its unaudited financial results for the three months ended March 31, 2026.

Icomera, a wholly owned subsidiary of Equans, today announced the launch of the XS1, a compact, connectivity‑focused rail router designed for deployments where reliable onboard connectivity is the primary requirement.

SHANGHAI, China, May 12, 2026 (GLOBE NEWSWIRE) -- Qfin Holdings, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qfin Holdings” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced that it will hold an annual general meeting of shareholders (the “AGM”) at 9:30 a.m. on June 30, 2026 (Beijing time) at the address of Building 1, No. 98 Qingyijiang Road, Putuo District, Shanghai 200331, People’s Republic of China for the purpose of considering and, if thought fit, re-appointing Deloitte Touche Tohmatsu and Deloitte Touche Tohmatsu Certified Public Accountants LLP as the auditors of the Company to hold office until the conclusion of the next annual general meeting of the Company and to authorize the board of directors of the Company to fix their remuneration for the year ending December 31, 2026.

BEIJING, China, May 12, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it will report its unaudited financial results for the first quarter of 2026 before the U.S. market opens on Thursday, May 28, 2026.

BEIJING, May 12, 2026 (GLOBE NEWSWIRE) -- BingEx Limited (“BingEx” or the “Company”) (Nasdaq: FLX), a leading on-demand dedicated courier services provider in China (branded as “FlashEx”), today announced that it will report its first quarter 2026 unaudited financial results on Thursday, May 21, 2026, before the open of U.S. markets.

BOCA RATON, Fla., May 12, 2026 (GLOBE NEWSWIRE) -- A majority of Hispanic consumers say their financial situation has gotten worse over the past year, a reversal from just three months ago, according to a new poll from Florida Atlantic University’s Business and Economic Polling Initiative.

Transaction in Own Shares   

Dijon, France, May 12, 2026 — EktaH, a clinical-stage biotechnology company, today reported positive preliminary Phase I results and preclinical data for its lead compound NKS-3, a modified fatty acid molecule and the first oral therapy designed to address key limitations of current GLP-1 obesity treatments.

Luxury Food. Global Brands. Duty-Free Value. From the Comfort of Home.

Leading Macau’s Non-Gaming Diversification Through Mice, Entertainment and Sporting Events

ORION CORPORATION PRESS RELEASE12 MAY 2026 at 10:30 EEST        

A Human-Centric Approach to Light Challenges Long-Standing Industry Assumptions

SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (Nasdaq: ECPG) (the “Company”) today announced its intention to offer, subject to market and other conditions, €300.0 million aggregate principal amount of senior secured floating rate notes due 2033 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) and outside the United States to non-U.S. persons (within the meaning of Regulation S under the Securities Act).

Press ReleaseNokia launches agentic AI for home and broadband networks

Paris, France – 12 MAY, 2026 (0830 CET)Enterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-target in vivo immune therapies shown to induce a rapid, long-lasting and potent expansion of specific memory T-cells to fight cancer, will present highly encouraging data for its lead OncoMimics™ immunotherapy EO2463 in indolent NHL at the Congress of the European Hematology Association (EHA) in June.

Progress on share buyback programme